Harel Insurance Investments & Financial Services Ltd. Has $7.03 Million Position in Chemed Corporation $CHE

Harel Insurance Investments & Financial Services Ltd. cut its holdings in Chemed Corporation (NYSE:CHE) by 7.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,615 shares of the company’s stock after selling 1,394 shares during the quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in Chemed were worth $7,032,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Monetary Solutions Ltd acquired a new position in shares of Chemed during the 4th quarter worth about $25,000. Los Angeles Capital Management LLC acquired a new stake in shares of Chemed in the 4th quarter valued at approximately $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed during the 4th quarter worth approximately $27,000. Global Retirement Partners LLC boosted its stake in Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after acquiring an additional 58 shares during the last quarter. Finally, Rothschild Investment LLC grew its holdings in Chemed by 800.0% during the fourth quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock valued at $46,000 after purchasing an additional 96 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on CHE shares. Royal Bank Of Canada increased their target price on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Wall Street Zen cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. Bank of America raised their price objective on Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a research note on Thursday, July 9th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Finally, Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $480.25.

Chemed Price Performance

CHE stock opened at $492.96 on Thursday. The stock has a 50-day moving average price of $447.15 and a two-hundred day moving average price of $429.88. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $497.25. The stock has a market cap of $6.54 billion, a PE ratio of 26.86, a price-to-earnings-growth ratio of 1.81 and a beta of 0.52. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.Chemed’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities analysts forecast that Chemed Corporation will post 22.67 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. Chemed’s dividend payout ratio is 13.08%.

Insider Activity at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 3.33% of the stock is owned by company insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.